- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Stage IB-IIA-IIIA Non-Small Cell Lung Cancer; EGFRm ; Ex19Del; L858R; AZD9291; Phase III, adjuvant c
Total 491145 results
-
AstraZenecaActive, not recruitingStage IB-IIIA Non-small Cell Lung CarcinomaUnited States, Italy, Netherlands, Belgium, Canada, Poland, Romania, Taiwan, Thailand, Vietnam, France, Brazil, Hungary, Japan, Russian Federation, Turkey, China, Korea, Republic of, Germany, Hong Kong, Spain, Australia, Israel, Ukraine, Swed...
-
Shaare Zedek Medical CenterAstraZenecaRecruiting
-
AstraZenecaActive, not recruitingAdvanced Non Small Cell Lung CancerCanada, Poland, Taiwan, United States, Korea, Republic of, Japan, Russian Federation, Ukraine
-
European Organisation for Research and Treatment...AstraZenecaActive, not recruitingNSCLCFrance, Spain, Slovenia, Jordan, Poland
-
Soroka University Medical CenterActive, not recruiting
-
AstraZenecaParexelActive, not recruitingLocally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung CancerBelgium, United States, Canada, Poland, Romania, Taiwan, Thailand, Vietnam, France, Italy, Korea, Republic of, Brazil, Japan, Turkey, China, Malaysia, Germany, Spain, Australia, Hungary, Portugal, Switzerland, Israel, Philippines, Russian... and more
-
AstraZenecaRecruitingNon-Small Cell Lung CancerUnited States, Spain, China, Italy, Turkey, Argentina, United Kingdom, Canada, Germany, Brazil, Vietnam, Thailand, Poland, Russian Federation, Japan, Korea, Republic of, Taiwan, Malaysia, Singapore, Romania
-
AstraZenecaNo longer available
-
AstraZenecaCompletedNon-small Cell Lung CancerSweden
-
AstraZenecaCompletedCarcinoma, Non-Small-Cell Lung With EGFR Mutation PositiveChina
-
AstraZenecaRecruitingStage II-IIIB Non-small Cell Lung CarcinomaSpain, Korea, Republic of, Philippines, Italy, United States, Malaysia, Taiwan, Thailand, Hong Kong, United Kingdom, Singapore
-
AstraZenecaCompletedAdvanced Non Small Cell Lung Cancer | Advanced (Inoperable) Non Small Cell Lung CancerFrance, Korea, Republic of, United Kingdom, Spain
-
AstraZenecaCompletedAdvanced Non Small Cell Lung Cancer | Advanced (Inoperable) Non Small Cell Lung CancerUnited States, France, Germany, Korea, Republic of, Taiwan, United Kingdom, Spain, Italy, Japan, Australia
-
AstraZenecaParexelWithdrawnNon Small Cell Lung CancerItaly, Russian Federation, Spain, China, Netherlands, United States, Taiwan, France, Germany
-
AstraZenecaCompletedLocally Advanced or Metastatic EGFR T790M+ NSCLCCanada, Korea, Republic of, Taiwan
-
Hellenic Oncology Research GroupUnknownNon Small Cell Lung CancerGreece
-
AstraZenecaParexelActive, not recruitingNon-small Cell Lung CancerItaly, Spain, United States, China, Germany, Israel
-
Tianjin Medical University Cancer Institute and...Recruiting
-
AstraZenecaActive, not recruitingNon-Small Cell Lung CancerKorea, Republic of, China, Australia
-
National University Hospital, SingaporeAstraZeneca; Singapore Clinical Research InstituteUnknownCarcinoma, Non-Small-Cell LungTaiwan, Hong Kong, Thailand, Singapore, Korea, Republic of
-
AstraZenecaCompletedNon Small Cell Lung CancerKorea, Republic of, Taiwan, United Kingdom, Spain, United States, Netherlands
-
AstraZenecaActive, not recruitingNon Small Cell Lung CancerBelgium, Korea, Republic of, Spain, United States, France
-
AstraZenecaCompletedNon Small Cell Lung CancerSpain, United Kingdom, France, United States
-
AstraZenecaParexelTerminatedNon Small Cell Lung CancerUnited States, Korea, Republic of
-
Dana-Farber Cancer InstituteNational Comprehensive Cancer NetworkActive, not recruitingNon-small Cell Lung CancerUnited States
-
AstraZenecaCompleted
-
AstraZenecaCompletedNon Small Cell Lung CancerItaly, United States, Canada, Korea, Republic of, Japan, Taiwan, Hong Kong, Spain
-
Ascentage Pharma Group Inc.Suzhou Yasheng Pharmaceutical Co., Ltd.RecruitingEGFR Positive Non-small Cell Lung CancerChina
-
AstraZenecaDaiichi SankyoNot yet recruitingNon-small Cell Lung CancerChina, Taiwan, Korea, Republic of, Australia
-
AstraZenecaCompletedHealthy VolunteerUnited States
-
Samsung Medical CenterActive, not recruitingNon-Small Cell Lung Cancer With EGFR T790M Mutation | With Brain and/or Leptomeningeal Metastasis | Failed Tyrosine Kinase InhibitorsKorea, Republic of
-
AstraZenecaParexelCompletedEGFR Mutation Positive Locally Advanced or Metastatic Non-Small Cell Lung CancerSpain, United States, Italy, Korea, Republic of, Malaysia
-
Oslo University HospitalAstraZenecaActive, not recruitingLung Cancer | Targeted TherapySweden, Finland, Denmark, Lithuania, Norway
-
AstraZenecaRecruitingNon-Small Cell Lung CancerChina, United States, Chile, Vietnam, Thailand, Brazil, Bulgaria, Canada, Germany, India, Japan, Korea, Republic of, Poland, Russian Federation, Singapore, Turkey, Austria, Israel, Spain, Taiwan, Mexico, France, Italy, Peru, Switzerland, United...
-
MedSIRAstraZenecaCompletedNon-Small Cell Lung CancerSpain
-
Dana-Farber Cancer InstituteAstraZenecaRecruiting
-
AstraZenecaCompletedEGFR Mutation Positive Advanced Non Small Cell Lung CancerUnited States, Korea, Republic of, Taiwan, Australia
-
AstraZenecaQuintiles, Inc.CompletedNon Small Cell Lung CancerKorea, Republic of, Spain, France
-
AstraZenecaCompletedNon Small Cell Lung CancerTaiwan
-
Shandong Cancer Hospital and InstituteAstraZenecaUnknownNonsmall Cell Lung Cancer | Brain Metastases | EGFR-TKI Resistant Mutation | AZD9291
-
Sun Yat-sen UniversityRecruitingNon-Small Cell Lung CancerChina
-
AstraZenecaParexelCompletedLung CancerCanada, Denmark, Italy, Spain, Belgium, Korea, Republic of, Brazil, China, Taiwan, Australia, Austria, United Kingdom, Sweden, Argentina, Saudi Arabia, Ireland
-
AstraZenecaActive, not recruitingAnticancer TreatmentUnited States, France, Germany, Spain, Sweden, United Kingdom, Canada, Italy, Korea, Republic of, Hungary, Japan, Russian Federation, China, Taiwan, Hong Kong, Netherlands, Australia, Mexico
-
AstraZenecaCompletedAdvanced Non Small Cell Lung Cancer | Advanced (Inoperable) Non Small Cell Lung CancerBelgium, United States, Korea, Republic of, Taiwan, United Kingdom, Netherlands
-
University of Texas Southwestern Medical CenterAstraZenecaActive, not recruitingNon-small Cell Lung Cancer (NSCLC)United States
-
Beijing Cancer Prevention & Treatment SocietyCancer Institute and Hospital, Chinese Academy of Medical SciencesRecruitingNon Small Cell Lung CancerChina
-
Chul KimBristol-Myers Squibb; AstraZeneca; Walter Reed National Military Medical Center; Hackensack Meridian HealthActive, not recruitingNonsmall Cell Lung Cancer | EGFR Gene MutationUnited States
-
AstraZenecaTerminated
-
AstraZenecaQuintiles, Inc.CompletedLocally Advanced or Metastatic Non-Small-Cell Lung Cancer (Stage IIIB-IV)United States